Please ensure Javascript is enabled for purposes of website accessibility

Life Technologies Buys KDR Biotech

By Rich Smith - Apr 13, 2013 at 2:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The hunted is still a hunter.

The Wall Street Journal calls Carlsbad, Calif.-based Life Technologies (NASDAQ: LIFE) an $11 billion "company you never heard of." As the Journal reports, a buyout group including private-equity powerhouses Blackstone (BX), Carlyle Group (CG), and KKR (KKR 5.75%) is putting together an $11 billion bid to acquire the lab research equipment manufacturer. But as it turns out, Life is doing a bit of acquiring itself.

On Friday, Life announced that it has purchased South Korean reagents distributor KDR Biotech, its own primary distributor on the Korean Peninsula, for an undisclosed sum. Life averred in a statement that it will continue selling plastic ware and similar products -- which it does not itself produce but which KDR had been in the business of distributing -- in South Korea going forward. Life also intends to absorb all of KDR's current employees, and to also take on its CEO as an "external advisor" during the integration process.

Life Technologies shares gained 1.8% on Friday, closing at $68. The company currently commands an $11.6 billion market capitalization, higher even than the Journal's reported buyout offer from Life's private-equity suitors.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Blackstone Group L.P. Stock Quote
The Blackstone Group L.P.
BX
Carlyle Group L.P. Stock Quote
Carlyle Group L.P.
CG
KKR & Co. Stock Quote
KKR & Co.
KKR
$53.51 (5.75%) $2.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
332%
 
S&P 500 Returns
118%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.